JPMorgan Chase & Co. purchased a new stake in Guardian Pharmacy Services, Inc. (NYSE:GRDN – Free Report) during the fourth quarter, HoldingsChannel.com reports. The fund purchased 3,785 shares of the company’s stock, valued at approximately $77,000.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Franklin Resources Inc. bought a new stake in Guardian Pharmacy Services in the 3rd quarter valued at approximately $8,575,000. Barclays PLC bought a new stake in shares of Guardian Pharmacy Services in the third quarter worth $311,000. Charles Schwab Investment Management Inc. acquired a new position in Guardian Pharmacy Services during the fourth quarter worth $544,000. Rhumbline Advisers bought a new position in Guardian Pharmacy Services in the fourth quarter valued at $149,000. Finally, New York State Common Retirement Fund grew its position in Guardian Pharmacy Services by 17.9% in the fourth quarter. New York State Common Retirement Fund now owns 278,548 shares of the company’s stock valued at $5,643,000 after purchasing an additional 42,368 shares in the last quarter.
Guardian Pharmacy Services Trading Up 1.0 %
Shares of Guardian Pharmacy Services stock opened at $25.67 on Wednesday. Guardian Pharmacy Services, Inc. has a 12-month low of $14.16 and a 12-month high of $25.98. The business’s 50 day moving average is $21.76 and its 200-day moving average is $21.40.
Analyst Ratings Changes
View Our Latest Report on GRDN
Guardian Pharmacy Services Company Profile
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
See Also
- Five stocks we like better than Guardian Pharmacy Services
- Pros And Cons Of Monthly Dividend Stocks
- 3 Mid-Cap Medical Stocks Outperforming the Market
- Dividend Capture Strategy: What You Need to Know
- The Top-Ranked Insider Buys From April by Market Cap
- What Are Treasury Bonds?
- Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?
Want to see what other hedge funds are holding GRDN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Guardian Pharmacy Services, Inc. (NYSE:GRDN – Free Report).
Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.
